ScreenerHero

RDHL RedHill Biopharma Ltd.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · redhillbio.com
0.4740USD-2.07%Mkt Cap: 4.21M $P/E: —

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in ad…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap4.21M USD
Enterprise Value-1.62M USD
Revenue (TTM)0 USD
Gross Profit0 USD
Net Income (TTM)-429.00K USD
Revenue/Share0.09 USD
Last Price0.4740 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)16.13
PEG—
EV/EBITDA0.20
EV/Revenue—
P/SInfinity
P/B0.58
EPS (TTM)0.00
EPS (Forward)0.03
52W Range
0.46470% of range2.790
52W High2.790 USD
52W Low0.4647 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-150.00%
ROE-10.05%
ROA-1.69%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.65M USD
CapEx (TTM)5.00K USD
FCF Margin—
FCF Yield123.27%
Net Debt-4.08M USD
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.25
Current Ratio0.34
Quick Ratio0.20
Book Value/Sh0.84 USD
Cash/Share1.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 20, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.89M
Float4.20M
Insiders0.00%
Institutions3.55%
Short Interest
Short Ratio0.0d
Short % Float3.93%
Short % Out.3.87%
Shares Short235.26K
Short (prev mo.)14.71K
Technical
SMA 500.6155 (-23.0%)
SMA 2000.8790 (-46.1%)
Beta4.90
S&P 52W Chg15.78%
Avg Vol (30d)311.74K
Avg Vol (10d)165.01K
Technical Indicators
RSI (14)34.7
MACD-0.0472
MACD Signal-0.0426
MACD Hist.-0.0046
BB Upper0.7165 USD
BB Middle0.5564 USD
BB Lower0.3964 USD
BB Width57.52%
ATR (14)0.0429 USD
Vol Ratio (20d)0.17x